Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers (Q24241136)

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Prophylactic intranasal mupirocin ointment in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical-site infection after digestive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Preventing surgical-site infections in nasal carriers of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Direct detection of Staphylococcus aureus from adult and neonate nasal swab specimens using real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Intranasal mupirocin prophylaxis in elective surgery. A review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Randomized Controlled Trial of Chlorhexidine Gluconate for Washing, Intranasal Mupirocin, and Rifampin and Doxycycline Versus No Treatment for the Eradication of Methicillin-Resistant Staphylococcus aureus Colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

7 January 2021

Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

7 January 2021

Delta APACHE II for predicting course and outcome of nosocomial Staphylococcus aureus bacteremia and its relation to host defense

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

7 January 2021

Treatment of familial staphylococcal infection--comparison of mupirocin nasal ointment and chlorhexidine/neomycin (Naseptin) cream in eradication of nasal carriage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

7 January 2021

The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

7 January 2021

Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

7 January 2021

Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006216.PUB2

7 January 2021

10.1002/14651858.CD006216.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2408389

2408389

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference